UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Use of Interferon Alfa in the Treatment of Myeloproliferative Neoplasms: Perspectives and Review of the Literature

Cancers, 2020-07, Vol.12 (7), p.1954

2020

Volltextzugriff (PDF)

P1029: JAK2‐CHIP IS ASSOCIATED WITH SIMILAR RISK OF CARDIOVASCULAR DISEASE AS JAK2‐MPN

HemaSphere, 2023-08, Vol.7 (S3), p.e8334975-n/a

2023

Volltextzugriff (PDF)

In-Hospital and readmission outcomes of patients with myeloproliferative neoplasms and heart failure: Insights from the National Readmissions Database

International journal of cardiology. Heart & vasculature, 2023-12, Vol.49, p.101304-101304, Article 101304

2023

Volltextzugriff (PDF)

Immune profiling of responses to influenza vaccination in patients with myeloproliferative neoplasms

EJHaem, 2024-06, Vol.5 (3), p.573-577

2024

Volltextzugriff (PDF)

Practice patterns and outcomes of direct oral anticoagulant use in myeloproliferative neoplasm patients

Blood cancer journal (New York), 2021-11, Vol.11 (11), p.176-176, Article 176

2021

Volltextzugriff (PDF)

Interferons as the First Choice of Cytoreduction in Essential Thrombocythemia and Polycythemia Vera

Journal of the National Comprehensive Cancer Network, 2022-09, Vol.20 (9), p.1063-1068

2022

Volltextzugriff (PDF)

A nonrandomized phase I and biomarker trial of regorafenib in advanced myeloid malignancies

EJHaem, 2022-05, Vol.3 (2), p.434-442

2022

Volltextzugriff (PDF)

Management Issues and Controversies in Low-Risk Patients with Essential Thrombocythemia and Polycythemia Vera

Current hematologic malignancy reports, 2021-10, Vol.16 (5), p.473-482

2021

Volltextzugriff (PDF)

Blast and accelerated phase CML: room for improvement

Hematology, 2021-12, Vol.2021 (1), p.122-128

2021

Volltextzugriff (PDF)

Abstract 11955: Hospital Readmission Outcomes After Myocardial Infarction Among Patients With Myeloproliferative Neoplasms

Circulation (New York, N.Y.), 2023-11, Vol.148 (Suppl_1)

2023

Volltextzugriff (PDF)

In-Hospital and readmission outcomes of patients with myeloproliferative neoplasms and atrial fibrillation: insights from the National Readmissions Database

Journal of thrombosis and thrombolysis, 2024-02, Vol.57 (2), p.186-193

2024

Volltextzugriff (PDF)

Prevention of recurrent thromboembolism in myeloproliferative neoplasms: review of literature and focus on direct oral anticoagulants: DOACs in MPNs

Postgraduate medicine, 2021-07, Vol.133 (5), p.508-516

2021

Volltextzugriff (PDF)

Abstract 12891: Outcomes After Heart Failure Hospitalization Among Patients With Myeloproliferative Neoplasms

Circulation (New York, N.Y.), 2023-11, Vol.148 (Suppl_1)

2023

Volltextzugriff (PDF)

Myeloproliferative Neoplasms Are Associated with Increased Risk of Major Adverse Limb Events Among Patients Hospitalized for Peripheral Arterial Disease

Blood, 2023-11, Vol.142 (Supplement 1), p.4570-4570

2023

Volltextzugriff (PDF)

Moving toward disease modification in polycythemia vera

Blood, 2023-11, Vol.142 (22), p.1859-1870

2023

Volltextzugriff (PDF)

A Practical Guide for Using Myelofibrosis Prognostic Models in the Clinic

Journal of the National Comprehensive Cancer Network, 2020-09, Vol.18 (9), p.1271-1278

2020

Volltextzugriff (PDF)

Distinct clinical, laboratory and molecular features of myeloproliferative neoplasm patients with splanchnic vein thrombosis

British journal of haematology, 2018-10, Vol.183 (2), p.310-313

2018

Volltextzugriff (PDF)

Immune Profiling of Responses to Influenza Vaccination in Patients with Myeloproliferative Neoplasms

Blood, 2021-11, Vol.138 (Supplement 1), p.3631-3631

2021

Volltextzugriff (PDF)

Myeloproliferative Neoplasms and Cardiovascular Disease: A Review

Current treatment options in oncology, 2024-09

2024

Volltextzugriff (PDF)

Chemotherapy-associated Posterior Reversible Encephalopathy Syndrome: A Case Report and Review of the Literature

The Neurologist (Baltimore, Md.), 2016-11, Vol.21 (6), p.112-117

2016

Volltextzugriff (PDF)

Immunologic Responses to Sars-Cov-2 Vaccination in Myeloproliferative Neoplasm Patients: Durability, Booster Responses, and Associations with Infections

Blood, 2022-11, Vol.140 (Supplement 1), p.6852-6853

2022

Volltextzugriff (PDF)

Immunogenicity and Reactogenicity of SARS-CoV-2 Vaccines in Patients With Cancer: The CANVAX Cohort Study

Journal of clinical oncology, 2022-01, Vol.40 (1), p.12-23

2022

Volltextzugriff (PDF)

Prevention of recurrent thromboembolism in myeloproliferative neoplasms: review of literature and focus on direct oral anticoagulants

Postgraduate medicine, 2021-06, Vol.133 (5), p.508-516

2021

Volltextzugriff (PDF)

Pulsatile Erlotinib in EGFR-Positive Non-Small Cell Lung Cancer Patients with Leptomeningeal and Brain Metastases: Review of the Literature

Clinical lung cancer, 2017-07, Vol.18 (4), p.354-363

2017

Volltextzugriff (PDF)

Cardiovascular Risk Factors Are Common in Myeloproliferative Neoplasms and Portend Worse Survival and Thrombotic Outcomes

Blood, 2023-11, Vol.142 (Supplement 1), p.4568-4568

2023

Volltextzugriff (PDF)

1 – 25 von 205.650

Suche als RSS-Feed

Aktive Filter

SpracheJapanisch

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(126.923)
Mit Volltextzugriff
(152.497)

Publikationsform

11 weitere anzeigen...

Weniger anzeigen...

Sprache

15 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

Science & Technology
(64.960)
Life Sciences & Biomedicine
(49.756)
Humans
(36.509)
Female
(20.840)
Male
(18.572)
Biological And Medical Sciences
(13.597)
Social Sciences
(13.099)
Adult
(11.284)
Middle Aged
(10.443)
Technology
(9.776)
Animals
(9.696)
Medical Sciences
(9.618)
Physical Sciences
(9.329)
Aged
(8.089)
Psychology
(5.230)
Adolescent
(5.009)
Fundamental And Applied Biological Sciences. Psychology
(4.556)
Nursing
(4.424)
Chemistry
(4.198)
Child
(4.067)

15 weitere anzeigen...

Weniger anzeigen...

Kollektion

EZB Electronic Journals Library
(58.022)
Ingenta.com
(55.975)
MEDLINE
(46.053)
Journals@Ovid Full Text
(38.704)
NUS Single-Journal Subscriptions
(35.368)
IngentaConnect Journals
(25.654)
JSTOR
(23.739)
Elsevier ScienceDirect Journals Collection
(23.218)
Wiley Blackwell Single Titles
(18.840)
Ebook Central Perpetual and DDA
(15.175)
Elsevier Journal Backfiles on ScienceDirect (DFG Nationallizenzen)
(15.051)
Nexis Uni
(14.813)
eBooks on EBSCOhost
(13.848)
Business Source Ultimate
(12.855)
Wiley Online Library
(12.674)
Taylor & Francis
(9.479)
Taylor & Francis Journals Complete
(9.476)
Taylor & Francis Journals Auto-Holdings Collection
(9.096)
SpringerLink_现刊
(8.196)
ProQuest Dissertations & Theses A&I
(7.594)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

Library Journal
(1.694)
Medical Economics
(1.471)
Plos One
(1.344)
Psychiatric News
(1.336)
The Times Educational Supplement
(1.307)
Blood
(799)
Chemical Engineering
(795)
Bloomberg Businessweek
(723)
The Spectator
(667)
Journal Of Clinical Oncology
(631)

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

Menü

Weitere Dienste

Einstellungen

Use of Interferon Alfa in the Treatment of Myeloproliferative Neoplasms: Perspectives and Review of the Literature

P1029: JAK2‐CHIP IS ASSOCIATED WITH SIMILAR RISK OF CARDIOVASCULAR DISEASE AS JAK2‐MPN

In-Hospital and readmission outcomes of patients with myeloproliferative neoplasms and heart failure: Insights from the National Readmissions Database

Immune profiling of responses to influenza vaccination in patients with myeloproliferative neoplasms

Practice patterns and outcomes of direct oral anticoagulant use in myeloproliferative neoplasm patients

Interferons as the First Choice of Cytoreduction in Essential Thrombocythemia and Polycythemia Vera

A nonrandomized phase I and biomarker trial of regorafenib in advanced myeloid malignancies

Management Issues and Controversies in Low-Risk Patients with Essential Thrombocythemia and Polycythemia Vera

Blast and accelerated phase CML: room for improvement

Abstract 11955: Hospital Readmission Outcomes After Myocardial Infarction Among Patients With Myeloproliferative Neoplasms

In-Hospital and readmission outcomes of patients with myeloproliferative neoplasms and atrial fibrillation: insights from the National Readmissions Database

Prevention of recurrent thromboembolism in myeloproliferative neoplasms: review of literature and focus on direct oral anticoagulants: DOACs in MPNs

Abstract 12891: Outcomes After Heart Failure Hospitalization Among Patients With Myeloproliferative Neoplasms

Myeloproliferative Neoplasms Are Associated with Increased Risk of Major Adverse Limb Events Among Patients Hospitalized for Peripheral Arterial Disease

Moving toward disease modification in polycythemia vera

A Practical Guide for Using Myelofibrosis Prognostic Models in the Clinic

Distinct clinical, laboratory and molecular features of myeloproliferative neoplasm patients with splanchnic vein thrombosis

Immune Profiling of Responses to Influenza Vaccination in Patients with Myeloproliferative Neoplasms

Myeloproliferative Neoplasms and Cardiovascular Disease: A Review

Chemotherapy-associated Posterior Reversible Encephalopathy Syndrome: A Case Report and Review of the Literature

Immunologic Responses to Sars-Cov-2 Vaccination in Myeloproliferative Neoplasm Patients: Durability, Booster Responses, and Associations with Infections

Immunogenicity and Reactogenicity of SARS-CoV-2 Vaccines in Patients With Cancer: The CANVAX Cohort Study

Prevention of recurrent thromboembolism in myeloproliferative neoplasms: review of literature and focus on direct oral anticoagulants

Pulsatile Erlotinib in EGFR-Positive Non-Small Cell Lung Cancer Patients with Leptomeningeal and Brain Metastases: Review of the Literature

Cardiovascular Risk Factors Are Common in Myeloproliferative Neoplasms and Portend Worse Survival and Thrombotic Outcomes

Aktive Filter

Suchergebnisse filtern